Reich, K.; Papp, K.; Blauvelt, A.; Langley, R.; Armstrong, A.; Warren, R.; Gordon, K.; Merola, J.; Madden, C.; Wang, M.; Vanvoorden, V.; Lebwohl, M. Efficacy and Safety of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study. J of Skin 2020, 4, s82.